Fundraising FoxBreakout Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Copernic develops catalysts for zero-carbon ammonia and e-fuels that are cost-competitive and compatible with existing industrial infrastructure.
CleantechClimate TechDeep TechEnergyCambridge, US
Aruna Ramkrishnan(Founder)inJacob Ebenstein Grose(Executive Officer, Director)
BoardLindy Fishburne(Director)inMichael Kearney(Director)inMichael LoCascio(Director)
Co-investorsFuture VenturesInnospark VenturesJuniperNew Climate VenturesThe Engine Ventures
.jpeg){kind=logo}
Passkey operates Locksmith, a computational platform that uses human genetics, biology, and pharmacology to identify synergistic drug combinations from approved and late-stage drugs, allowing existing assets to be repurposed for new indications.
AI & Machine LearningBiotechDeep Tech
Co-investorsBison VenturesWireframe VenturesInnovation Endeavors
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersGlobal BioAccess FundNorwest Venture PartnersOSF VenturesSeroba Life Sciences+3 more
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Chief Executive Officer & Co-Founder)inLindy Fishburne(Director)Phil Grayeski(Director)Taehong Huh(Director)Timothy Dummer(Executive Officer, Director)Jon Kuchenreuther(Co-Founder)
Co-investorsAccelr8Breakout LabsCavallo VenturesDudley FundFreshTracks CapitalKdT Ventures+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.